A Prospective Decision Impact Study to Evaluate the Utility of the Oncotype DX Breast DCIS Score Assay in Selecting Patients with Ductal Carcinoma in Situ (DCIS) Following Breast Conservation Surgery (BCS) for Radiotherapy.